Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects.
Fausto AlmeidaJulie M WolfThiago Aparecido da SilvaCarlos M DeLeon-RodriguezCaroline Patini RezendeAndré Moreira PessoniFabrício Freitas FernandesRafael Silva-RochaRoberto MartinezMarcio Lourenço RodriguesMaria Cristina Roque-BarreiraArturo CasadevallPublished in: Nature communications (2017)
Cryptococcus neoformans is an encapsulated fungal pathogen that causes cryptococcosis, which is a major opportunistic infection in immunosuppressed individuals. Mammalian β-galactoside-binding protein Galectin-3 (Gal-3) modulates the host innate and adaptive immunity, and plays significant roles during microbial infections including some fungal diseases. Here we show that this protein plays a role also in C. neoformans infection. We find augmented Gal-3 serum levels in human and experimental infections, as well as in spleen, lung, and brain tissues of infected mice. Gal-3-deficient mice are more susceptible to cryptococcosis than WT animals, as demonstrated by the higher fungal burden and lower animal survival. In vitro experiments show that Gal-3 inhibits fungal growth and exerts a direct lytic effect on C. neoformans extracellular vesicles (EVs). Our results indicate a direct role for Gal-3 in antifungal immunity whereby this molecule affects the outcome of C. neoformans infection by inhibiting fungal growth and reducing EV stability, which in turn could benefit the host.